Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2025 ,inter alia, to consider and approve To consider and approve to raise ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has informed BSE that its Board of Directors will meet on 26th June 2025 to consider raising funds by issuing Convertible Equity Warrants, which can be converted into equity shares of face value Rs. 10 each. The warrants will be issued via Preferential Issue and Private Placement, possibly in one or more tranches, subject to shareholder, regulatory and statutory approvals. The Board will also decide on convening an Extraordinary General Meeting (EGM) to seek shareholder approval for the issuance. The trading window for designated persons and their immediate relatives has been closed from the date of this notice until 48 hours after the board meeting concludes.
If approved, this fund-raising move could lead to dilution of existing shareholders' stake but bring fresh capital into the company. Retail investors should watch for pricing details, number of warrants and proposed allottees once formally announced, as preferential issues are typically directed at specific investors.